$0.00
(Market cap
$42 Mln
Recently Viewed
Clear AllMarket cap
$42 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-- Mln
ROE
-0.2 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
5.3
Debt to Equity
0.5
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
54,681,335
CFO
₪19.28 Mln
EBITDA
₪115.08 Mln
Net Profit
₪-72.34 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
INC Research Holdings Inc (INCR)
| -1.4 | 16.5 | -3.8 | -38.6 | -26.4 | -35.3 | -- |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|
|
INC Research Holdings Inc (INCR)
| -42.8 | -60.9 | -49.1 | 398.5 | 4.8 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company... offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. Read more
CEO & Director
Mr. Alexander Rabinovich
CEO & Director
Mr. Alexander Rabinovich
Headquarters
Herzliya
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of INC Research Holdings Inc (INCR) is $0.90 (NASDAQ) as of 24-Apr-2026 10:32 EDT. INC Research Holdings Inc (INCR) has given a return of -26.4% in the last 3 years.
Since, TTM earnings of INC Research Holdings Inc (INCR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
3.31
|
0.30
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of INC Research Holdings Inc (INCR) are Rs 1.77 and Rs 0.68 as of 24-Apr-2026.
INC Research Holdings Inc (INCR) has a market capitalisation of $ 42 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in INC Research Holdings Inc (INCR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.